Patents by Inventor Christopher R. Emerson

Christopher R. Emerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Activated Cannabinoid Controlled Release Compound Tablet and Method of Forming The Same
    Publication number: 20250057769
    Abstract: An activated cannabinoid controlled release compound tablet and method of forming the same. In one embodiment, the tablet includes a cannabinoid and a hosting compound mixed with the cannabinoid to form a cannabinoid controlled release compound.
    Type: Application
    Filed: August 29, 2024
    Publication date: February 20, 2025
    Applicant: Metta Medical Inc.
    Inventors: Christopher R. Emerson, Christopher M. Antapli, Flip Senn
  • Activated cannabinoid controlled release compound tablet and method of forming the same
    Patent number: 12076442
    Abstract: An activated cannabinoid controlled release compound tablet and method of forming the same. In one embodiment, the tablet includes a cannabinoid and a hosting compound mixed with the cannabinoid to form a cannabinoid controlled release compound.
    Type: Grant
    Filed: December 6, 2022
    Date of Patent: September 3, 2024
    Assignee: METTA MEDICAL INC
    Inventors: Christopher R. Emerson, Christopher M. Antapli, Flip Senn
  • Activated cannabinoid controlled release compound tablet and method of forming the same
    Patent number: 11596606
    Abstract: An activated cannabinoid controlled release compound tablet and method of forming the same. In one embodiment, the tablet includes a cannabinoid and a hosting compound mixed with the cannabinoid to form a cannabinoid controlled release compound. The tablet may also include a surfactant mixed with the cannabinoid controlled release compound to form an activated cannabinoid controlled release compound.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: March 7, 2023
    Assignee: METTA MEDICAL INC
    Inventors: Christopher R. Emerson, Christopher M. Antapli, Flip Senn
  • Activated Cannabinoid Controlled Release Compound Tablet and Method of Forming The Same
    Publication number: 20200375907
    Abstract: An activated cannabinoid controlled release compound tablet and method of forming the same. In one embodiment, the tablet includes a cannabinoid and a hosting compound mixed with the cannabinoid to form a cannabinoid controlled release compound. The tablet may also include a surfactant mixed with the cannabinoid controlled release compound to form an activated cannabinoid controlled release compound.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 3, 2020
    Applicant: Metta Medical Inc. (dba Level)
    Inventors: Christopher R. Emerson, Christopher M. Antapli, Flip Senn